NO910868L - Antiglaukompreparater inneholdende 3-arylkarbonyl-1-aminoalkyl-1h-indol og fremgangsmaate for fremstilling derav. - Google Patents

Antiglaukompreparater inneholdende 3-arylkarbonyl-1-aminoalkyl-1h-indol og fremgangsmaate for fremstilling derav.

Info

Publication number
NO910868L
NO910868L NO91910868A NO910868A NO910868L NO 910868 L NO910868 L NO 910868L NO 91910868 A NO91910868 A NO 91910868A NO 910868 A NO910868 A NO 910868A NO 910868 L NO910868 L NO 910868L
Authority
NO
Norway
Prior art keywords
aminoalkyl
compositions containing
antiglauc
indol
procedures
Prior art date
Application number
NO91910868A
Other languages
English (en)
Other versions
NO910868D0 (no
NO179612B (no
NO179612C (no
Inventor
Susan Jean Ward
Malcolm Rice Bell
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of NO910868D0 publication Critical patent/NO910868D0/no
Publication of NO910868L publication Critical patent/NO910868L/no
Publication of NO179612B publication Critical patent/NO179612B/no
Publication of NO179612C publication Critical patent/NO179612C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO910868A 1990-03-08 1991-03-05 Analogifremgangsmåte for fremstilling av 3-arylkarbonyl-1-aminoalkyl-1H-indol-forbindelser NO179612C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49020190A 1990-03-08 1990-03-08

Publications (4)

Publication Number Publication Date
NO910868D0 NO910868D0 (no) 1991-03-05
NO910868L true NO910868L (no) 1991-09-09
NO179612B NO179612B (no) 1996-08-05
NO179612C NO179612C (no) 1996-11-13

Family

ID=23947024

Family Applications (1)

Application Number Title Priority Date Filing Date
NO910868A NO179612C (no) 1990-03-08 1991-03-05 Analogifremgangsmåte for fremstilling av 3-arylkarbonyl-1-aminoalkyl-1H-indol-forbindelser

Country Status (21)

Country Link
EP (1) EP0445781B1 (no)
JP (1) JP3157179B2 (no)
KR (1) KR0183396B1 (no)
AT (1) ATE133663T1 (no)
AU (1) AU643757B2 (no)
CA (1) CA2036307C (no)
DE (1) DE69116705T2 (no)
DK (1) DK0445781T3 (no)
ES (1) ES2082872T3 (no)
FI (1) FI95369C (no)
GR (1) GR3019058T3 (no)
HU (1) HU215125B (no)
IE (1) IE72953B1 (no)
IL (1) IL97426A (no)
MX (1) MX174433B (no)
MY (1) MY106109A (no)
NO (1) NO179612C (no)
NZ (1) NZ237309A (no)
PH (1) PH27022A (no)
PT (1) PT96938B (no)
RU (1) RU2073670C1 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5068234A (en) * 1990-02-26 1991-11-26 Sterling Drug Inc. 3-arylcarbonyl-1-(c-attached-n-heteryl)-1h-indoles
GB9204365D0 (en) * 1992-02-28 1992-04-08 Pfizer Ltd Indoles
FR2713224B1 (fr) * 1993-12-02 1996-03-01 Sanofi Sa N-pipéridino-3-pyrazolecarboxamide substitué.
FR2713225B1 (fr) * 1993-12-02 1996-03-01 Sanofi Sa N-pipéridino-3-pyrazolecarboxamide substitué.
FR2692575B1 (fr) * 1992-06-23 1995-06-30 Sanofi Elf Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
ES2099007B1 (es) * 1993-07-16 1997-12-01 Pfizer Res & Dev Derivados de indol.
FR2714057B1 (fr) * 1993-12-17 1996-03-08 Sanofi Elf Nouveaux dérivés du 3-pyrazolecarboxamide, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DE69921314T2 (de) * 1998-05-01 2006-02-09 Eli Lilly And Co., Indianapolis INHIBITORISCHE ESTER FÜR sPLA 2
PT985414E (pt) * 1998-05-26 2004-01-30 Pfizer Prod Inc Metodo de tratamento de glaucoma e retinopatia isquemica
WO2001040183A1 (en) * 1999-12-03 2001-06-07 Alcon Universal Ltd. 1-aminoalkyl-1h-indoles for treating glaucoma
ATE409491T1 (de) * 2000-01-18 2008-10-15 Merck & Co Inc Orhthalmologische zusammenstellungen zur behandlung von ocularer hypertension
CA2399791A1 (en) * 2000-02-11 2001-08-16 Bristol-Myers Squibb Company Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases
SE0203070D0 (en) * 2002-10-16 2002-10-16 Astrazeneca Ab Novel compounds
TW200508197A (en) * 2003-03-31 2005-03-01 Ucb Sa Indolone-acetamide derivatives, processes for preparing them and their uses
FR2893615B1 (fr) * 2005-11-18 2008-03-07 Sanofi Aventis Sa Derives de 3-acylindole, leur preparation et leur application en therapeutique
KR101723125B1 (ko) 2015-07-29 2017-04-04 이은솔 개선된 구조의 위생 젓가락
JP6025234B1 (ja) * 2016-03-10 2016-11-16 株式会社サンライフ 箸における箸置き形成方法及び箸置き機能を有する箸
CN107628981B (zh) * 2017-10-31 2019-07-30 威海市妇女儿童医院 一种肉桂酰基吲哚啉化合物及其制备青光眼药物的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1436771A (en) * 1973-02-16 1976-05-26 Labaz Indole derivatives and process for preparing the same
US4581354A (en) * 1984-08-06 1986-04-08 Sterling Drug Inc. 3-arylcarbonyl- and 3-cycloalkylcarbonyl-1-aminoalkyl-1H-indoles, compositions and use
US4634776A (en) * 1984-08-06 1987-01-06 Sterling Drug, Inc. 3-arylcarbonyl-and 3-cycloalkylcarbonyl-1-aminoalkyl-1H-indoles
US4634698A (en) * 1984-09-24 1987-01-06 Schering Corporation Antiglaucoma agents
DE3821148A1 (de) * 1988-06-23 1989-12-28 Erwin Von Dr Angerer Aminoalkylindole, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate

Also Published As

Publication number Publication date
KR910016745A (ko) 1991-11-05
PH27022A (en) 1993-02-01
HU215125B (hu) 1998-09-28
NZ237309A (en) 1993-02-25
HUT56492A (en) 1991-09-30
ES2082872T3 (es) 1996-04-01
MX174433B (es) 1994-05-16
GR3019058T3 (en) 1996-05-31
CA2036307A1 (en) 1991-09-09
EP0445781A1 (en) 1991-09-11
MY106109A (en) 1995-03-31
FI911131A (fi) 1991-09-09
AU7266991A (en) 1991-09-12
NO910868D0 (no) 1991-03-05
DE69116705D1 (de) 1996-03-14
FI911131A0 (fi) 1991-03-06
PT96938B (pt) 1998-07-31
DE69116705T2 (de) 1996-09-26
JP3157179B2 (ja) 2001-04-16
IE910700A1 (en) 1991-09-11
IE72953B1 (en) 1997-05-07
JPH04235164A (ja) 1992-08-24
MX24839A (es) 1993-10-01
AU643757B2 (en) 1993-11-25
DK0445781T3 (da) 1996-02-19
FI95369C (fi) 1996-01-25
IL97426A (en) 1996-03-31
KR0183396B1 (ko) 1999-05-01
NO179612B (no) 1996-08-05
CA2036307C (en) 2002-07-09
FI95369B (fi) 1995-10-13
ATE133663T1 (de) 1996-02-15
IL97426A0 (en) 1992-06-21
PT96938A (pt) 1991-10-31
EP0445781B1 (en) 1996-01-31
RU2073670C1 (ru) 1997-02-20
NO179612C (no) 1996-11-13

Similar Documents

Publication Publication Date Title
NO910868D0 (no) Antiglaukompreparater inneholdende 3-arylkarbonyl-1-aminoalkyl-1h-indol og fremgangsmaate for fremstilling derav.
DE69121211T2 (de) Applanationstonometer
ES2071227T3 (es) Composicion para gotas para los ojos.
PL285248A1 (en) Method of obtaining novel aminophenol derivatives
IT1240683B (it) Composizione farmaceutica contenente egf
ATE117208T1 (de) Behandlung von intraokularem druck mit einer ophthalmischen synergistischen kombination.
FI891473A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 4-aryyli-4-piperidiinikarbinolien valmistamiseksi
DE3761523D1 (de) Verfahren und zusammensetzung zur bekaempfung der vitrifikation waehrend der in-vitro-mikrovermehrung von pflanzen.
DK379387A (da) Optisk rene 1,3-dioxenoner, fremgangsmaade til fremstilling deraf og anvendelse heraf
DE69100171D1 (de) Synergistische kombination zur ophthalmischen verwendung.
PT87563A (pt) Process for the preparation of vinylcephalosporins useful as medicaments
DK0458537T3 (da) Anvendelse af en terapeutisk forbindelse til behandling af bronkitis
DK467983A (da) Mikroporoes ferrosilicat og fremgangsmaade til fremstilling af samme
RU1799875C (ru) Способ получени сополимеров на основе N-винилпирролидона дл м гких контактных линз
DE3767940D1 (de) Pyranderivate.
IE801737L (en) (20 s) 3ó-aminoacetamido-5ó-pregnan-20-ol

Legal Events

Date Code Title Description
MK1K Patent expired